NCT01693640View on ClinicalTrials.gov

A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 28, 2018

Study Completion Date

December 28, 2018

Conditions

Female Patients With Behcet's Syndrome

Interventions

DRUG

Abatacept

Weekly injections with Abatacept 125 mg over 6 months

Trial Locations (1)

10016

NYU Center for Musculoskeletal Care, New York

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

NYU Langone Health

OTHER